A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma
FRONTIERS IN PHARMACOLOGY（2022）
Key words
lung adenocarcinoma,TEAD4,prognostic signature,immune microenvironment estimation,biomarker
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined